Dr. Bilal Chughtai, MD
Claim this profileWeill Cornell Medicine
Studies Benign Prostatic Hyperplasia
Studies Skin Hyperplasia
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Weill Cornell Medicine
Weil Cornell Medical College, Cornell University
Clinical Trials Bilal Chughtai, MD is currently running
iTind vs UroLift
for Enlarged Prostate
This trial aims to compare the safety of the iTind device with UroLift for men who have urinary problems because of an enlarged prostate. The iTind device temporarily reshapes the prostate tissue to help improve urine flow. iTIND is the second-generation version of a temporary implantable device, which is one of the latest minimally invasive surgeries available to treat bothersome lower urinary tract symptoms caused by benign prostate enlargement.
Recruiting1 award N/A8 criteria
Rezum vs UroLift
for Enlarged Prostate
C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.
Recruiting1 award N/A5 criteria
More about Bilal Chughtai, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Bilal Chughtai, MD has experience with
- Rezum
- UroLift
- CAN-Stim - Protect CAN-Stim System
- SNS - InterStim® System
- Onabotulinumtoxin A
- PureWick System
Breakdown of trials Bilal Chughtai, MD has run
Benign Prostatic Hyperplasia
Skin Hyperplasia
Enlarged Prostate
Urinary Incontinence
Urge Incontinence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bilal Chughtai, MD specialize in?
Bilal Chughtai, MD focuses on Benign Prostatic Hyperplasia and Skin Hyperplasia. In particular, much of their work with Benign Prostatic Hyperplasia has involved treating patients, or patients who are undergoing treatment.
Is Bilal Chughtai, MD currently recruiting for clinical trials?
Yes, Bilal Chughtai, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Bilal Chughtai, MD has studied deeply?
Yes, Bilal Chughtai, MD has studied treatments such as Rezum, UroLift, CAN-Stim - Protect CAN-Stim System.
What is the best way to schedule an appointment with Bilal Chughtai, MD?
Apply for one of the trials that Bilal Chughtai, MD is conducting.
What is the office address of Bilal Chughtai, MD?
The office of Bilal Chughtai, MD is located at: Weill Cornell Medicine, New York, New York 10065 United States. This is the address for their practice at the Weill Cornell Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.